Inmunocel | Las Condes, Chile

Research site

Location

Del Inca 4446 Oficina 401, Las Condes, Región Metropolitana de Santiago, Chile

Site insights

Top conditions

Top treatments

Bendamustine

Prednisone

Rusfertide

Upadacitinib

Doxorubicin

Vincristine

Cyclophosphamide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Jose Vinuela

Verified by this site

Active trials

3 of 3 total trials

A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera (VERIFY)

The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and...

Active, not recruiting

Polycythemia Vera

Drug: Placebo

Drug: Rusfertide

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma (OLYMPIA-1)

This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously u...

Enrolling

Follicular Lymphoma (FL)

Drug: Odronextamab

Drug: Rituximab

Locations recently updated

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus (SELECT-SLE)

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how s...

Enrolling

Systemic Lupus Erythematosus

Drug: Upadacitinib

Drug: Placebo

Trial sponsors

P

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms